Catalyst Funds Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-400
Closed -$28.1K 441
2024
Q3
$28.1K Buy
+400
New +$28.1K 0.01% 1001